Selective Safety Data Collection in Clinical Studies of Oncology Drugs for Marketing Approval in the United States. Journal of Regulatory Science, [S. l.], v. 5, n. 2, p. 36–44, 2017. DOI: 10.21423/JRS-V05N02P029. Disponível em: https://regsci-ojs-tamu.tdl.org/regsci/article/view/67.. Acesso em: 16 sep. 2024.